Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
37,570,941
-
Share change
-
-1,846,071
-
Total reported value
-
$721,322,587
-
Put/Call ratio
-
92%
-
Price per share
-
$19.20
-
Number of holders
-
133
-
Value change
-
-$62,306,470
-
Number of buys
-
63
-
Number of sells
-
79
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q1 2016
As of 31 Mar 2016 CLOVIS ONCOLOGY INC - COM (CLVSQ) had 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 37,570,941 shares of stock of the company.
Largest 10 holders included PointState Capital LP, Palo Alto Investors, LLC, Redmile Group, LLC, VANGUARD GROUP INC, HealthCor Management, L.P., Partner Fund Management, L.P., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, and OppenheimerFunds, Inc..
This table shows 133 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.